Lupus Erythematosus, Systemic
"Lupus Erythematosus, Systemic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Descriptor ID |
D008180
|
| MeSH Number(s) |
C17.300.480 C20.111.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lupus Erythematosus, Systemic".
Below are MeSH descriptors whose meaning is more specific than "Lupus Erythematosus, Systemic".
This graph shows the total number of publications written about "Lupus Erythematosus, Systemic" by people in this website by year, and whether "Lupus Erythematosus, Systemic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 0 | 3 |
| 2012 | 2 | 1 | 3 |
| 2013 | 3 | 2 | 5 |
| 2014 | 3 | 1 | 4 |
| 2015 | 3 | 0 | 3 |
| 2016 | 6 | 1 | 7 |
| 2017 | 101 | 10 | 111 |
| 2018 | 91 | 7 | 98 |
| 2019 | 21 | 9 | 30 |
| 2020 | 29 | 10 | 39 |
| 2021 | 13 | 3 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "Lupus Erythematosus, Systemic" by people in Profiles.
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
-
The Emergence of new-onset SLE following SARS-CoV-2 vaccination. QJM. 2021 12 20; 114(10):739-740.
-
Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll-like receptors 7 and 8. Pharmacol Res Perspect. 2021 10; 9(5):e00842.
-
Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine. Dermatol Ther. 2021 11; 34(6):e15114.
-
Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis. Rheumatol Int. 2021 Nov; 41(11):1925-1931.
-
Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America. Lupus. 2021 Oct; 30(12):1879-1887.
-
20-Year-old female with fever, cough, and dyspnea: Acute lupus pneumonitis during the pandemic of coronavirus disease 2019 (COVID-19). Lupus. 2021 Oct; 30(11):1856-1862.
-
High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection. BMJ Case Rep. 2021 Aug 25; 14(8).
-
Systemic lupus erythematosus after COVID-19 vaccination: A case report. J Cosmet Dermatol. 2021 Oct; 20(10):3103-3104.
-
Adaptive Immunity and the Risk of Autoreactivity in COVID-19. Int J Mol Sci. 2021 Aug 20; 22(16).